Can-Fite BioPharma Ltd.
CANF
$1.20
-$0.03-2.44%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.89M | 7.89M | 4.73M | 4.73M | 8.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.02M | 1.02M | 1.10M | 1.10M | 908.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 77.00K | 77.00K | -- | -- | 78.00K |
| Total Current Assets | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M |
|
|
|||||
| Total Current Assets | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M |
| Net Property, Plant & Equipment | 138.00K | 138.00K | 94.00K | 94.00K | 81.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.12M | 9.12M | 5.92M | 5.92M | 9.99M |
|
|
|||||
| Total Accounts Payable | 618.00K | 618.00K | 885.00K | 885.00K | 427.00K |
| Total Accrued Expenses | 976.00K | 976.00K | 430.00K | 430.00K | 944.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.00K | 53.00K | 36.00K | 36.00K | 27.00K |
| Total Finance Division Other Current Liabilities | 405.00K | 405.00K | 636.00K | 636.00K | 622.00K |
| Total Other Current Liabilities | 405.00K | 405.00K | 636.00K | 636.00K | 622.00K |
| Total Current Liabilities | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M |
|
|
|||||
| Total Current Liabilities | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 51.00K | 51.00K | 21.00K | 21.00K | 13.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.58M | 1.58M | 1.44M | 1.44M | 1.71M |
| Total Liabilities | 3.68M | 3.68M | 3.44M | 3.44M | 3.75M |
|
|
|||||
| Common Stock & APIC | 170.67M | 170.67M | 163.79M | 163.79M | 163.60M |
| Retained Earnings | -166.36M | -166.36M | -162.44M | -162.44M | -158.48M |
| Treasury Stock & Other | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Total Common Equity | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M |
|
|
|||||